Selected article for: "immune response innate and innate immune response"
Author: Aran Singanayagam; Su-Ling Loo; Maria Calderazzo; Lydia J Finney; Maria-Belen Trujillo Torralbo; Eteri Bakhsoliani; Jason Girkin; Punnam Veerati; Prabuddha S Pathinayake; Kristy S Nichol; Andrew Reid; Joseph Foottit; Sebastian L Johnston; Nathan W Bartlett; Patrick Mallia
Title: Anti-microbial immunity is impaired in COPD patients with frequent exacerbations
  • Document date: 2019_5_9
    • ID: 72jzqm86_49
    Snippet: Our study provides the first evidence that frequent exacerbators have innate anti-viral immune dysfunction, suggesting that a reduction in interferon production might underlie an augmented propensity to virus infections and thus increased exacerbation frequency observed in these patients. This mechanism is supported by a clinical study which reported that COPD patients who are frequent exacerbators experience significantly more coryzal episodes t.....
    Document: Our study provides the first evidence that frequent exacerbators have innate anti-viral immune dysfunction, suggesting that a reduction in interferon production might underlie an augmented propensity to virus infections and thus increased exacerbation frequency observed in these patients. This mechanism is supported by a clinical study which reported that COPD patients who are frequent exacerbators experience significantly more coryzal episodes than infrequent exacerbators 26 . Given that inhaled IFN-β therapy has been shown to confer clinical benefit in a subgroup of severe asthmatic patients who develop a cold 27 , our data raises suggestion that such innate immune-boosting therapies could be effective when used in a targeted manner in patients with COPD with evidence of frequent exacerbations and a less effective innate immune response.

    Search related documents:
    Co phrase search for related documents
    • clinical benefit and immune dysfunction: 1, 2
    • clinical benefit and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
    • clinical benefit and innate immune response: 1, 2
    • clinical benefit and interferon production: 1
    • clinical benefit and virus infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • clinical benefit confer and immune response: 1
    • clinical study and copd patient: 1, 2, 3
    • clinical study and exacerbation frequency: 1, 2
    • clinical study and frequent exacerbation: 1